Good luck with your investment journey.
With the recent positive announcements from each company (RAC, IMU, CHM) and after getting "comfortable" with each company, CHM stands out as the most compelling.
* Very low MC
* Very good results that are streamlined to treating SPECIFIC cancers
* Small team
* I feel Jen Chow has really proven herself as a mover and shaker. I feel that the last acquisition from IMU was mostly due to her.
I for one really believe out of IMU, RAC and CHM, that CHM is the superior investment.
Ann: 1st patient dosed in Phase 1b recurrent glioblastoma trial, page-37
Add CHM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
1.5¢ |
Change
-0.001(6.25%) |
Mkt cap ! $13.40M | |||
| Open | High | Low | Value | Volume |
| 1.6¢ | 1.6¢ | 1.5¢ | $18.74K | 1.223M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 20 | 2926082 | 1.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 1.6¢ | 74491 | 1 |
View Market Depth
| Last trade - 16.10pm 17/09/2024 (20 minute delay) ? |
| CHM (ASX) Chart |